Please click here to obtain permission to reproduce this image.
Click on image to view larger version.

Figure 2 Each of the individual factors which favor management decisions for respective therapeutic options in patients with obstructive hypertrophic cardiomyopathy and drug-refractory severe symptoms (New York Heart Association functional classes III/IV). LVH = left ventricular hypertrophy; MAZE = surgical procedure to abolish atrial fibrillation.
|